Source:http://linkedlifedata.com/resource/pubmed/id/15538542
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2004-11-11
|
pubmed:abstractText |
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, characterized by progressive impairment of cognitive functions. AD has a strong and complex genetic etiology, and multiple genes, acting independently and/or interacting, likely to influence the risk of developing AD. To test whether the expression of Fas receptor is upregulated in peripheral blood T lymphocytes and whether or not it correlates with APOE genotypes, 88 patients with AD and 24 normal individuals as controls were included in this study. T lymphocytes from patients as opposed to controls did undergo DNA fragmentation after in vitro exposure to IgM anti-Fas. In addition, several activation markers (CD25, HLA-DR, and CD45R0) were increased after 72 h in culture with respect to the controls, and Fas expression was also significantly different from the control group (p < 0.01). Reverse transcription PCR for Fas mRNA yielded the same results. T cells from both patients and controls showed upregulation of Fas receptor expression after in vitro anti-CD3 stimulation. Co-culture experiments with interleukin-4 downmodulated surface Fas receptor expression on T cells from patients and at a lesser extent in the control group. AD patients with the APOE allele 4 showed an increased expression of CD95 (53% +/- 6) with respect to APOE allele 3 (38% +/- 4). The control group showed a 22% +/- 3 (allele 4) and 31% +/- 5 (allele 3), respectively. Hyperexpression of Fas mRNA and surface Fas receptor on CD45RO(+) T lymphocytes may explain the occurrence of inflammatory cellular infiltrates in the CNS of AD patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/anti-Fas monoclonal antibody
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0379-0355
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
523-9
|
pubmed:meshHeading |
pubmed-meshheading:15538542-Aged,
pubmed-meshheading:15538542-Alzheimer Disease,
pubmed-meshheading:15538542-Antibodies, Monoclonal,
pubmed-meshheading:15538542-Antigens, CD95,
pubmed-meshheading:15538542-Apolipoproteins E,
pubmed-meshheading:15538542-Case-Control Studies,
pubmed-meshheading:15538542-DNA Fragmentation,
pubmed-meshheading:15538542-Female,
pubmed-meshheading:15538542-Genotype,
pubmed-meshheading:15538542-Humans,
pubmed-meshheading:15538542-Male,
pubmed-meshheading:15538542-Middle Aged,
pubmed-meshheading:15538542-RNA, Messenger,
pubmed-meshheading:15538542-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:15538542-T-Lymphocytes
|
pubmed:year |
2004
|
pubmed:articleTitle |
Association between APOE epsilon4 allele and increased expression of CD95 on T cells from patients with Alzheimer's disease.
|
pubmed:affiliation |
EBIOTEC, Biotechnology Division, La Coruna, Spain. biotecnologia@ebiotec.com
|
pubmed:publicationType |
Journal Article
|